The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Last updated: December 9, 2024
Sponsor: Ruijin Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Thyroid Cancer

Treatment

N/A

Clinical Study ID

NCT06730529
RuijinH 2024-498
  • Ages 16-80
  • All Genders

Study Summary

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Pathological and clinical diagnosis of thyroid cancer with lymph node metastases.

  2. Signed and dated informed consent form.

  3. Commitment to comply with research procedures and co-operation in the implementationof the full research process.

  4. Aged 16-80 years old.

Exclusion

Exclusion Criteria:

  1. Patients with serious illnesses that researchers consider unsuitable forparticipation in this clinical study. Such as severe heart and lung failure, severebone marrow suppression, severe liver and kidney dysfunction, etc.

  2. Intestinal perforation, complete intestinal obstruction.

  3. Pregnant women and women who may be pregnant, women who are breastfeeding.

  4. Non-compliant person.

Study Design

Total Participants: 40
Study Start date:
November 29, 2024
Estimated Completion Date:
December 31, 2029

Study Description

The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo a 68Ga-FAPI PET/CT before surgery. The imaging response measurements will be compared with the histopathological results as gold standard.

Connect with a study center

  • Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

    Shanghai, Shanghai 200001
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.